Avalor Therapeutics
Kenmore, US · Founded 2020 · Delaware corporation
Founders & leadership
WE
William E. Martinez ZegarraNamed on SEC filing
AF
Anthony FordNamed on SEC filing
KW
Kenneth WildNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$335K disclosed across 1 round · 2023
▶$335KraisedDec 2023 · 6 investors · BiotechnologyRule 506(b)
▶$335KraisedDec 2023 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William E. Martinez ZegarraExecutive Officer, Director
- Anthony FordDirector
- Kenneth WildDirector
- Offering amount
- $800K
- Amount sold
- $335K
- Minimum investment
- $25K
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Avalor Therapeutics raised?
- Avalor Therapeutics has disclosed $335K raised across 1 round.
- Where is Avalor Therapeutics headquartered?
- Avalor Therapeutics is headquartered in Kenmore, US.